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Summary
Objective: To examine whether phosphocitrate (PC) will block nitric oxide-induced calcification of cartilage or chondrocyte-derived apoptotic
bodies.
Design: Articular cartilage vesicles (ACV) or apoptotic bodies (AB) were isolated from untreated or 1 mM sodium nitroprusside (SNP) treated
porcine cartilage slices. Mineralization of ACV, AB, control untreated and SNP-treated cartilage were done in the presence or absence of PC
(1 mM)±ATP (1 mM).
Results: PC [1 mM] blocked both the ATP-dependent and -independent mineralization in ACV and AB, untreated and SNP treated cartilage.
Moreover, PC had no effect on NTPPPH activity in either ACV or AB fraction in the presence or absence of ATP suggesting that PC did not
block the mineralization through the inhibition of NTPPPH activity.
Conclusions: PC inhibits nitric oxide-induced calcification of cartilage and cartilage-derived apoptotic bodies.
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A reduction in tissue cellularity and abnormal matrix calci-
fication are among the age-related changes in cartilage.1,2
To test the hypothesis that apoptosis may contribute to the
abnormal calcification of articular cartilage in aging and
osteoarthritis, Hashimoto et al.1 demonstrated that human
chondrocytes exposed to nitric oxide (NO) undergo cell
death by apoptosis. In the NO treated cartilage, the dense
pericellular matrix that normally surrounds the cells is
degraded and apoptotic bodies accumulate within and in
the vicinity of the chondrocytes lacunae.7. Chondrocyte-
derived apoptotic bodies (AB) are known to produce
inorganic pyrophosphate (PPi) when exposed to ATP. The
levels of PPi produced by AB are increased by pretreat-
ment with TGF-â and decrease by IL-1. AB contains
alkaline phosphatase and NTPPH activities and precipitate
calcium. The enrichment of phosphate and PPI-generating
enzyme in AP should facilitate formation of basic calcium
phosphate (BCP) and calcium pyrophosphate dihydrate
(CPPD) crystals, both of which occur with increased
prevalence in aging and osteoarthritic cartilage.2–4
Our present understanding of the mechanisms of patho-
logical and age-related calcification is limited, therefore no
reliable method has been formulated to prevent calcium409crystal deposition. Phosphocitrate (PC) is a naturally occur-
ring compound, which has been identified in mammalian
mitochondria and crab hepatopancreas.5 It has been
speculated that PC may have an important role in prevent-
ing calcium phosphate precipitation in cells or cellular
compartments maintaining high concentration of calcium
and phosphate.5 PC prevents soft tissue calcification in
vivo and does not produce any significant toxic effect in rat
or mouse when administered through injections in doses up
to 150 ìmole/kg/day.6,7
Articular cartilage vesicles (ACV), isolated by differential
centrifugation of adult hyaline articular cartilage colla-
genase digests, mineralized in the presence of calcium and
ATP. These structures are analogous to matrix vesicles,
putative sites of BCP mineralization in epiphyseal cartilage
or healing fracture. Mineral analysis of ACV by microscopy,
chemical analysis, energy dispersive analysis, electron
beam diffraction, and FTIR revealed that CPPD-like
crystals were the predominant species formed by ACV in
the presence of ATP, while BCP crystals were the primary
crystals formed in the absence of ATP.3 Native adult
articular cartilage also underwent ATP-dependent mineral-
ization as did isolated ACV, supporting the contention that
vesicles fostered adult articular cartilage mineralization.
This in-vitro model may serve as a model for the study of
chondrocalcinosis caused by BCP and CPPD.8
Recently, we demonstrated for the first time that PC
(10–1000 uM) blocked both the ATP-dependent and
independent mineralization in ACV in a dose dependent
fashion.9 Similarly, PC blocked both the ATP-dependent
and independent mineralization in native articular cartilage
410 H. S. Cheung and L. M. Ryan: Phosphocitrate blocks nitric oxide-induced calcification of cartilageslices. We further showed that PC had no effect on ACV
NTPPPH activity, suggesting that PC did not block the
mineralization through the inhibition of NTPPPH activity
which generates PPi from ATP. Since PC blocked both
ATP-dependent and independent mineralization in both
systems, diffusion of PC through the cartilage matrix to
block mineralization in cartilage is likely.9
In the present study, we examine whether PC will inhibit
NO-induced calcification of cartilage or AB.Experimental procedures
Dulbecco’s modified Eagle medium (DMEM), Hanks’
balanced salt solution without calcium and magnesium
(HBSS), fetal bovine serum (FBS), Pen-Strep-Fungizone
(PSF), and HEPES buffer were obtained from Gibco
(Grand Island, NY). [45Ca]-labeled CaCl2 was from
Amersham (Arlington Heights, VA). Gamma [32P] ATP was
from obtained from New England Nuclear (Boston, MA).
Collagenase, trypsin, hyaluronidase, ATP, and AMP were
from Sigma (St Louis, MO). Protein assay reagents for cell
protein measurements were from Bio-Rad (Richmond, CA).
PC was prepared as the sodium salt by phosphorylation of
tribenyl citrate followed by deprotection through hydro-
genation. The monosodium salt was crystallized from
water.9
Induction of apoptosis in cartilage was carried out
according to Hashimoto et al.1 Briefly, cartilage slices were
incubated 1 mM sodium nitroprusside (SNP) for 24 h. ACV
and AB isolation were carried out according to the pro-
cedure as outlined by Derfus et al.3 Hyaline articular
cartilage was obtained from femoral condyles and patellae
of freshly slaughtered pigs. Cartilage slices were sequen-
tially treated with 0.1% [w/v] hyaluronidase and 0.5% [w/v]
trypsin for 10 min each, then digested with 0.05% [w/v]
collagenase overnight. The cartilage digest was serially
centrifuged in a Beckman L-8-80M ultracentrifuge
(Beckman, Irvine, CA) according to the following protocol:
300 g for 10 min to remove intact cells; 20,000 g for 10 min
to remove larger cell fragments; then 50,000 g for 60 min to
pellet the ACV/AB. These fractions were washed twice and
resuspended in HBSS to a final concentration of 3–6 mg
protein/ml.
ACV/AB mineralization was assayed in the presence or
absence of PC in a calcifying salt solution (CSS) containing
2.2 mM CaCl2, 1.6 mM KH2PO4, 1 mM MgCl2, 85 mM
NaCl, 15 mM KCl, 10 mM NaHCO3, 50 mM n-tris(hydroxymethyl) methyl-2-aminoethanesulfonic acid, and
1 mM ATP, pH 7.6.2,3,9 Twenty-five ml of ACV suspension
was added to 500 Fl of CSS in 1.5 ml polypropylene tubes,
vortexed, and incubated in a 37°C water bath. CSS was
labeled with 1 ìCi/ml of 45Ca. After 48 h, samples were
centrifuged at 10,000 g for 10 min. Supernatant was
removed and pellet was washed twice by resuspension in
500 ìl of ice-cold CSS without ATP, and centrifuged after
each wash at 10,000 g for 10 min. 45Ca contained in the
mineral phase was solubilized with concentrated HCl and
counted in a Beckman liquid scintillation counter.
Native articular cartilage mineralization assay was per-
formed according to Ryan et al.8 Briefly, SNP treated or
untreated control pig hyaline articular cartilage slices were
cultured in a 20-fold [v/wet weight] volume of 50 mM
HEPES-buffered DMEM, pH 7.4, containing 10% FBS.
Medium was trace-labeled with 45Ca [1 ìCi/ml]. ATP-
dependent mineralization was measured as cartilage
retention of [45Ca] counts after incubation with ATP. Aconcentrated stock solution of 0.1 M ATP in buffered
DMEM was freshly prepared and added to the explant
cultures to bring the media to 100 ìM with respect to ATP.
After 48 h, the incubations were terminated by transferring
cartilage to a separate plate and washing extensively with
buffered DMEM. Cartilage was then hydrolyzed by heating
to 70°C in 6 N HCl for 1 h. Aliquots of the digest were
counted for [45Ca].
NTPPPH enzyme activity assay was performed by com-
bining a 100 ìl sample with 100 ìl 2 mM thymidine mono-
phosphate n-nitrophenyl ester, 50 mM HEPES-buffered
HBSS, pH 7.4. The mixture was incubated at 37°C for 2 h
before terminating the reaction by addition of 800 ìl 0.1 N
NaOH. The p-nitrophenol product was determined by spec-
trophotometer at 410 nm. Triple determinations were made
on all samples. NTPPPH activity is expressed as nmol of
n-nitrophenol formed/h/mg protein.8 Measurements are
expressed as the means±S.D. All experiments were
repeated at least three times. The Wilcoxon rank sum test
was used to compare paired samples.3000
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Fig. 1. Effect of PC on mineralization by AB and ACV. AB and ACV
were isolated by differential centrifugation of collagenase digested
either normal adult hyaline cartilage or cartilage treated with
sodium nitroprusside (1 mM). ATP dependent and independent
mineralization assays were performed in the presence or absence
of PC in a calcifying salt solution (CSS). Twenty-five ml of ACV/AB
suspension was added to 500 ìl of CSS in 1.5 ml polypropylene
tubes, vortexed, and incubated in a 37°C water bath. CSS was
labeled with 1ìCi/ml of 45Ca. After 48 h, samples were centrifuged
at 10,000 g for 10 min. Supernatant was removed and pellet was
washed twice by resuspension in 500 ìl of ice-cold CSS without
ATP, and centrifuged after each wash at 10,000 g for 10 min. 45Ca
contained in the mineral phase was solubilized with concentrated
HCl and counted. , ATP-independent; , ATP-dependent; ,
ATP-independent; , ATP-dependent.Results
PC [1 mM] blocked both the ATP-dependent and
-independent mineralization in ACV and AB, SNP treated-
and untreated control cartilage (Figs 1 and 2). Both ACV
and AB possessed very high NTPPPH specific activity. PC
had no effect on NTPPPH activity in either ACV or AB
fraction in the presence or absence of ATP (Table I)
suggesting that PC did not block the mineralization through
the inhibition of NTPPPH activity.9
Compensated polarized light microscopy of similarly
prepared samples incubated in the absence of PC con-
firmed a population of strongly positively birefringent, rod-
shaped crystals. This appearance is very similar to that of
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In the present study, both the AB and SNP-treated
cartilage were used to examine the effect of PC on the
ATP-dependent and -independent mineralization. The
native cartilage and ACV isolated from untreated cartilage
were used as a control.
Recently, Derfus et al. reported that CPPD-like crystals
were the predominant species formed in the presence of
ATP while BCP crystals were the primary crystals formed in
the absence of ATP in the ACV mineralization model.3 We
have previously shown that PC can inhibit of both BCP and
CPPD crystal formation.9 Since PC blocked both ATP-
independent and -independent mineralization in AB and
SNP treated cartilage explants (Figs 1 and 2), this provides
the first evidence suggesting that PC can specifically
inhibit the formation of both forms of crystals by AB and
SNP-treated cartilage.
As in the ACV/AB system, the cartilage explant mineral-
ization requires hydrolysis of ATP to produce PPi. NTPPPHis the enzyme responsible for generation of PPi from
extracellular ATP in cartilage. It is a membrane-associated
ectoenzyme found in cell membrane and vesicle fraction of
adult articular cartilage.4 Since PC, had little effect on the
NTPPPH enzyme activity in ACV or AB, the possibility that
PC inhibits CPPD crystal formation through inhibition of
NTPPPH activity is unlikely (Table I).
Our earlier studies have shown that PC specifically
inhibits CPPD and BCP crystal-induced metalloproteinase
synthesis and mitogenesis in human fibroblasts in vitro,
while PC has no effect on similar biologic responses
induced by growth factors.6,11–13 PC blocked both the BCP
and CPPD crystal formation in a dose-dependent fashion in
both articular cartilage vesicle and articular cartilage.7
PC prevents disease progression in murine progressive
ankylosis (an animal model of crystal deposition diseases),
a condition marked by extensive BCP deposition.7 Taken
together with the present data, PC may be considered a
potential therapeutic agent for both CPPD and BCP crystal
deposition diseases. Our working hypothesis is that PC will
have dual beneficial effects of blocking the degeneration-
promoting effects of crystals e.g., metalloproteinase syn-
thesis and mitogenesis,4 and of inhibiting further BCP and
CPPD crystal formation in articular tissue.9,13
The inhibitory effect of PC on pathologic formation is
relevant whether BCP and CPPD crystals form in ACV
and/or AB.3000
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Fig. 2. Effect of PC on native articular cartilage mineralization in
the absence ( ) or presence ( ) of 1 mM SNP. Mineralization
assay was performed according to Ryan et al.6 Briefly, pig hyaline
articular cartilage slices were cultured in a 20-fold [v/wet weight]
volume of 50 mM HEPES-buffered DMEM, pH 7.4, containing
0.35 mg/ml BSA. Medium was trace-labeled with 45Ca. ATP-
dependent mineralization in the presence or absence of PC was
measured as cartilage retention of [45Ca] counts after incubation
with ATP. A concentrated stock solution of 0.1 M ATP in buffered
DMEM was freshly prepared and added to the explants cultures to
bring the media to 100 ìM with respect to ATP. After 48 h, the
incubations were concluded by transferring cartilage to a separate
plate and washing extensively with buffered DMEM. Cartilage was
then hydrolysed by heating to 70°C in 6 N HCl for 1 h. Aliquots of
the digest were counted for 45Ca. References
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